Skip to main content
Erschienen in: Acta Diabetologica 7/2018

16.04.2018 | Original Article

Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis

verfasst von: Maria Apostolopoulou, Barbara Menart-Houtermans, Ruth Ruetter, Bettina Nowotny, Ulrich Gehrmann, Daniel Markgraf, Julia Szendroedi, Nanette C. Schloot, Michael Roden

Erschienen in: Acta Diabetologica | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Aims

Infiltration of pancreatic islets with different leukocyte subtypes likely contributes to deterioration of glycemia in diabetes mellitus. Different subsets of leukocytes have been previously associated with type 1 or type 2 diabetes. This study aimed at examining these subsets at different stages of diabetes progression and possible relationships with metabolic parameters.

Methods

A total of 206 patients, 76 with type 1 and 130 with type 2 diabetes, were studied within the first year of diabetes diagnosis. In addition, 31 patients with type 1 and 73 with type 2 diabetes were examined at 5 years after diagnosis. Whole body insulin sensitivity was assessed by hyperinsulinemic–euglycemic clamps; insulin secretion by glucagon stimulation tests and white blood cells were analyzed by flow cytometry.

Results

The percentage of peripheral CD8+ cells was 15% lower in patients with type 1 diabetes at 5 years than in patients at diabetes onset and correlated positively with fasting glycemia, total cholesterol and high-sensitive C-reactive protein (hsCRP) (all r > 0.37, p < 0.05), but not with insulin secretion. Patients with type 2 diabetes had 7% higher percentages of CD4+ cells after 5 years than those at diagnosis. CD4+ cells correlated with hsCRP (r = 0.36, p < 0.05), whereas CD8+ cytotoxic T-cells did not correlate with any metabolic parameter.

Conclusion

CD8+ T-cells associate with worse glycemia, lipidemia and inflammation after 5 years of type 1 diabetes, whereas CD4+ T-cells associate with increased inflammation after 5 years upon onset of type 2 diabetes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
3.
Zurück zum Zitat Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metab Clin Exp 64:1629–1639CrossRefPubMed Kaul K, Apostolopoulou M, Roden M (2015) Insulin resistance in type 1 diabetes mellitus. Metab Clin Exp 64:1629–1639CrossRefPubMed
4.
5.
Zurück zum Zitat Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890CrossRefPubMedPubMedCentral Rodriguez-Calvo T, Ekwall O, Amirian N, Zapardiel-Gonzalo J, von Herrath MG (2014) Increased immune cell infiltration of the exocrine pancreas: a possible contribution to the pathogenesis of type 1 diabetes. Diabetes 63:3880–3890CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Lundberg M, Seiron P, Ingvast S, Korsgren O, Skog O (2017) Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia 60:346–353CrossRefPubMed Lundberg M, Seiron P, Ingvast S, Korsgren O, Skog O (2017) Insulitis in human diabetes: a histological evaluation of donor pancreases. Diabetologia 60:346–353CrossRefPubMed
7.
Zurück zum Zitat Williams MD, Nadler JL (2007) Inflammatory mechanisms of diabetic complications. Curr Diabetes Rep 7:242–248CrossRef Williams MD, Nadler JL (2007) Inflammatory mechanisms of diabetic complications. Curr Diabetes Rep 7:242–248CrossRef
8.
Zurück zum Zitat Menart-Houtermans B, Rutter R, Nowotny B et al (2014) Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37:2326–2333CrossRefPubMed Menart-Houtermans B, Rutter R, Nowotny B et al (2014) Leukocyte profiles differ between type 1 and type 2 diabetes and are associated with metabolic phenotypes: results from the German Diabetes Study (GDS). Diabetes Care 37:2326–2333CrossRefPubMed
9.
Zurück zum Zitat Sarikonda G, Pettus J, Phatak S et al (2014) CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun 50:77–82CrossRefPubMed Sarikonda G, Pettus J, Phatak S et al (2014) CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes. J Autoimmun 50:77–82CrossRefPubMed
10.
Zurück zum Zitat Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRefPubMed Donath MY, Shoelson SE (2011) Type 2 diabetes as an inflammatory disease. Nat Rev Immunol 11:98–107CrossRefPubMed
12.
Zurück zum Zitat Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143CrossRefPubMed Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143CrossRefPubMed
13.
Zurück zum Zitat Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive beta-cell functional decline in type 2 diabetes. Diabetes Care 37:3286–3293CrossRefPubMedPubMedCentral Brooks-Worrell BM, Boyko EJ, Palmer JP (2014) Impact of islet autoimmunity on the progressive beta-cell functional decline in type 2 diabetes. Diabetes Care 37:3286–3293CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):S161–S164CrossRefPubMed Donath MY, Schumann DM, Faulenbach M, Ellingsgaard H, Perren A, Ehses JA (2008) Islet inflammation in type 2 diabetes: from metabolic stress to therapy. Diabetes Care 31(Suppl 2):S161–S164CrossRefPubMed
16.
Zurück zum Zitat Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971CrossRefPubMedPubMedCentral Greenbaum CJ, Mandrup-Poulsen T, McGee PF et al (2008) Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes. Diabetes Care 31:1966–1971CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ (2005) Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 28:1710–1717CrossRefPubMed Chung FM, Tsai JC, Chang DM, Shin SJ, Lee YJ (2005) Peripheral total and differential leukocyte count in diabetic nephropathy: the relationship of plasma leptin to leukocytosis. Diabetes Care 28:1710–1717CrossRefPubMed
18.
Zurück zum Zitat Pertynska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM (2004) Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 28:35–47CrossRefPubMed Pertynska-Marczewska M, Kiriakidis S, Wait R, Beech J, Feldmann M, Paleolog EM (2004) Advanced glycation end products upregulate angiogenic and pro-inflammatory cytokine production in human monocyte/macrophages. Cytokine 28:35–47CrossRefPubMed
19.
Zurück zum Zitat Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8:709–716CrossRefPubMed Sell H, Habich C, Eckel J (2012) Adaptive immunity in obesity and insulin resistance. Nat Rev Endocrinol 8:709–716CrossRefPubMed
20.
Zurück zum Zitat McLaughlin T, Liu LF, Lamendola C et al (2014) T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34:2637–2643CrossRefPubMedPubMedCentral McLaughlin T, Liu LF, Lamendola C et al (2014) T-cell profile in adipose tissue is associated with insulin resistance and systemic inflammation in humans. Arterioscler Thromb Vasc Biol 34:2637–2643CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Valle A, Giamporcaro GM, Scavini M et al (2013) Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 62:2072–2077CrossRefPubMedPubMedCentral Valle A, Giamporcaro GM, Scavini M et al (2013) Reduction of circulating neutrophils precedes and accompanies type 1 diabetes. Diabetes 62:2072–2077CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301–309CrossRefPubMedPubMedCentral Patsouris D, Li PP, Thapar D, Chapman J, Olefsky JM, Neels JG (2008) Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab 8:301–309CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–107CrossRefPubMed Cnop M, Welsh N, Jonas JC, Jorns A, Lenzen S, Eizirik DL (2005) Mechanisms of pancreatic beta-cell death in type 1 and type 2 diabetes: many differences, few similarities. Diabetes 54(Suppl 2):S97–107CrossRefPubMed
24.
Zurück zum Zitat Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60CrossRefPubMedPubMedCentral Coppieters KT, Dotta F, Amirian N et al (2012) Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients. J Exp Med 209:51–60CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun Héè L (2014) Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5:470CrossRefPubMedPubMedCentral Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun Héè L (2014) Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol 5:470CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (2005) 31:1420–1428CrossRef Zeyda M, Farmer D, Todoric J et al (2007) Human adipose tissue macrophages are of an anti-inflammatory phenotype but capable of excessive pro-inflammatory mediator production. Int J Obes (2005) 31:1420–1428CrossRef
27.
Zurück zum Zitat Dworacka M, Wesolowska A, Wysocka E, Winiarska H, Iskakova S, Dworacki G (2014) Circulating CD3+56+ cell subset in pre-diabetes. Exp Clin Endocrinol Diabetes Off J Germ Soc Endocrinol Germ Diabetes Assoc 122:65–70 Dworacka M, Wesolowska A, Wysocka E, Winiarska H, Iskakova S, Dworacki G (2014) Circulating CD3+56+ cell subset in pre-diabetes. Exp Clin Endocrinol Diabetes Off J Germ Soc Endocrinol Germ Diabetes Assoc 122:65–70
Metadaten
Titel
Characterization of circulating leukocytes and correlation of leukocyte subsets with metabolic parameters 1 and 5 years after diabetes diagnosis
verfasst von
Maria Apostolopoulou
Barbara Menart-Houtermans
Ruth Ruetter
Bettina Nowotny
Ulrich Gehrmann
Daniel Markgraf
Julia Szendroedi
Nanette C. Schloot
Michael Roden
Publikationsdatum
16.04.2018
Verlag
Springer Milan
Erschienen in
Acta Diabetologica / Ausgabe 7/2018
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-018-1143-x

Weitere Artikel der Ausgabe 7/2018

Acta Diabetologica 7/2018 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.